Internal Server Error

Pear Bio - About the company

Pear Bio is a series A company based in London (United Kingdom), founded in 2017 by Duleek Ranatunga. It operates as a Developer of microfluidic chip for cancer drug research. Pear Bio has raised $14.2M in funding from Octopus Ventures. The company has 91 active competitors, including 30 funded and 2 that have exited. Its top competitors include companies like Pandorum, InSphero and Newcells Biotech.

Company Details

Pear Bio develops microfluidic chip for cancer drug research. The device combines tissue engineering, microfluidics, and biomaterials to represent how drugs are infused, distributed and exposed to the tumor over multiple passes during a chemo regimen. It also maps the spread of cancer using 3D imaging.
Social
X
Key Metrics
Founded Year
2017
Location
Stage
Series A
Total Funding
$14.2M in 3 rounds
Latest Funding Round
Ranked
Employee Count
8 as on Sep 30, 2026
Similar Companies
Sign up to download Pear Bio's company profile

Pear Bio's funding and investors

Pear Bio has raised a total funding of $14.2M over 3 rounds. Its first funding round was on 2017. Its latest funding round was a Series A round on Apr 14, 2023 for $*****. 6 investors participated in its latest round. Pear Bio has 11 institutional investors.

Here is the list of recent funding rounds of Pear Bio:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Apr 14, 2023
5524963
Series A
9028266
7839056
3858312
6532502
Jan 15, 2019
3808081
Seed
2981371
4443323
4045385
2017
8415
Grant (prize money)
2247
4395
1380
lockAccess funding benchmarks and valuations. Sign up today!

Pear Bio's founders and board of directors

Founder? Claim Profile
The founders of Pear Bio is Duleek Ranatunga. Duleek Ranatunga is the CEO of Pear Bio.
Here are the details of Pear Bio's key team members:

Pear Bio's employee count trend

Pear Bio has 8 employees as of Sep 26. Here is Pear Bio's employee count trend over the years:
Employee count trend for Pear Bio
lockUncover Pear Bio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Pear Bio's Competitors and alternates

Top competitors of Pear Bio include Pandorum, InSphero and Newcells Biotech. Here is the list of Top 10 competitors of Pear Bio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Pandorum
Pandorum
2011, Bengaluru (India), Series B
Developer of regenerative medicine and 3D tissues
$52.1M
65/100
2nd
Logo for InSphero
InSphero
2009, Schlieren (Switzerland), Series D
Developer of cell based assays for drug screening
$35M
62/100
3rd
Logo for Newcells Biotech
Newcells Biotech
2014, Newcastle Upon Tyne (United Kingdom), Series B
Developer of induced pluripotent stem cells derived organoid models for research application
$14.4M
59/100
4th
Logo for Parallel Bio
Parallel Bio
2020, Cambridge (United States), Series A
Limited information available
$25.4M
54/100
5th
Logo for OncoPrecision
OncoPrecision
2020, Cordoba (Argentina), Seed
Developer of personalized assays for oncology precision therapy
$4.2M
51/100
6th
Logo for Nextandbio
Nextandbio
2019, Seoul (South Korea), Series A
Provider of organoid technology to develop customized treatments for patients
$5.27M
48/100
7th
Logo for Xilis
Xilis
2019, Durham (United States), Series B
Developer of drug discovery and precision therapy platform for oncology
$116M
46/100
8th
Logo for Mestastop
Mestastop
2018, Bengaluru (India), Seed
Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics
$1.29M
44/100
9th
Logo for Pear Bio
Pear Bio
2017, London (United Kingdom), Series A
Developer of microfluidic chip for cancer drug research
$14.2M
44/100
10th
Logo for BioDimension
BioDimension
2021, Bengaluru (India), Seed
Developer of biofabricating human tissues and organoids to make research
$983K
44/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Pear Bio's competitors? Click here to see the top ones

Pear Bio's Investments and acquisitions

Pear Bio has made no investments or acquisitions yet.

Reports related to Pear Bio

Here is the latest report on Pear Bio's sector:

News related to Pear Bio

•
Cytiva, Pear Bio Partner on Personalized Cancer MedicineContract Pharma•Sep 26, 2024•Cytiva, Pear Bio
•
PEAR-TNBC recruits first patientPear Bio•Jun 29, 2022•Pear Bio
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Pear Bio

Explore our recently published companies
  • Solar NRJ - Czech Republic based, 2026 founded, Unfunded company
  • HOP - San Francisco based, 2019 founded, Unfunded company
  • Subteno - Alencon based, 2008 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford